NTC, Phase

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

NTC Srl Switzerland Italy Germany United Kingdom France Netherlands Spain Belgium Austria United States of America

View original content:https://www.prnewswire.co.uk/news-releases/ntc-presents-positive-results-from-phase-ii-mirakle-study-evaluating-an-innovative-drug-for-bacterial-conjunctivitis-302321325.html

en | boerse | 67962835 |